Welcome to my most current weekly newsletter about the marijuana and psychedelics markets. It’s difficult to cover all the interesting research study in psychedelics, however addiction treatment is a reoccurring style. This week I look at the potential customers for treating one of the most commonly used and mistreated drugs: alcohol.
A brand-new licensing offer for ketamine in the US reveals the growing aspirations of the psychedelics market to reward addiction.